SNOW and Pharming Featured in the PM360 Innovations Issue The RUCONEST® (C1 esterase inhibitor ) Account Takeovers have been selected as this year’s Innovative Strategy in the PM360 Innovations Issue. In 2021, Pharming partnered with Snow Companies to transform RUCONEST’s social media channels. We launched four patient “accou Written by Oliver Portmann December 14, 2021December 14, 2021
Every Pharma Marketer Should Apply These Regulatory Safeguards By Nicole Hoadley In March, I had the opportunity to participate in a panel at DIA. The topic was on influencer marketing and its legal and regulatory implications. The somewhat inconsistent way professionals use the vernacular is what stood out to me the most. We should fix that by clarifying Written by Snow Staff April 19, 2021April 20, 2022
The End of DTC? Time to Rethink Patient Engagement Written by Snow Staff November 11, 2025November 11, 2025
From Outreach to Ownership: Why Co-Creation Can’t Wait Written by Snow Staff September 25, 2025October 23, 2025
Beyond Awareness: Modeling Shared Decision-Making in Patient Communications Written by Snow Staff May 15, 2025October 23, 2025
Publication Day! Brenda Snow’s “Diagnosed” Available Now Written by Oliver Portmann March 18, 2025March 18, 2025
The Hidden Value of Patient Voices: Redefining Success in Healthcare Written by Amelia Eanes March 11, 2025October 23, 2025
